CGM was associated with improved psychosocial health in patients with T2D using insulin (61, 62); therefore, it seems reasonable to deduce that patients with mental health impairment, such as depression or anxiety, would benefit from CGM use. This evidence concerns the gene INS and depressive symptom measurement.